JP2002535293A - 無針の経皮的粉末薬物送達を増強する方法 - Google Patents

無針の経皮的粉末薬物送達を増強する方法

Info

Publication number
JP2002535293A
JP2002535293A JP2000594511A JP2000594511A JP2002535293A JP 2002535293 A JP2002535293 A JP 2002535293A JP 2000594511 A JP2000594511 A JP 2000594511A JP 2000594511 A JP2000594511 A JP 2000594511A JP 2002535293 A JP2002535293 A JP 2002535293A
Authority
JP
Japan
Prior art keywords
skin
particles
therapeutic agent
use according
delivery device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000594511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002535293A5 (enExample
Inventor
スン−ユン クウォン，
テリー リー バーコス，
Original Assignee
パウダージェクト リサーチ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by パウダージェクト リサーチ リミテッド filed Critical パウダージェクト リサーチ リミテッド
Publication of JP2002535293A publication Critical patent/JP2002535293A/ja
Publication of JP2002535293A5 publication Critical patent/JP2002535293A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
JP2000594511A 1999-01-22 2000-01-21 無針の経皮的粉末薬物送達を増強する方法 Pending JP2002535293A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23594499A 1999-01-22 1999-01-22
US11690799P 1999-01-22 1999-01-22
US60/116,907 1999-01-22
US09/235,944 1999-01-22
PCT/GB2000/000156 WO2000043058A1 (en) 1999-01-22 2000-01-21 Method of enhancing needleless transdermal powdered drug delivery

Publications (2)

Publication Number Publication Date
JP2002535293A true JP2002535293A (ja) 2002-10-22
JP2002535293A5 JP2002535293A5 (enExample) 2007-03-29

Family

ID=26814746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000594511A Pending JP2002535293A (ja) 1999-01-22 2000-01-21 無針の経皮的粉末薬物送達を増強する方法

Country Status (6)

Country Link
EP (1) EP1148902A1 (enExample)
JP (1) JP2002535293A (enExample)
AU (1) AU765429B2 (enExample)
CA (1) CA2358584A1 (enExample)
IL (2) IL144380A0 (enExample)
WO (1) WO2000043058A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006335754A (ja) * 2005-06-01 2006-12-14 Technofarm Axesz Kk 経皮投与剤担持薄膜とその製造法
JP2013539688A (ja) * 2010-10-07 2013-10-28 マサチューセッツ インスティテュート オブ テクノロジー ローレンツ力直動型の無針式ジェット注射システムを用いた固形物および／または流体の供給
JP2022553563A (ja) * 2019-11-01 2022-12-23 ダーレ エムビー インコーポレイテッド 二段階マイクロチップ薬物送達デバイスおよび方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780397B2 (en) 1999-02-03 2005-03-17 Powderject Research Limited Hydrogel particle formulations
FR2822049B1 (fr) 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
US7635488B2 (en) 2001-03-13 2009-12-22 Dbv Technologies Patches and uses thereof
FR2921562B1 (fr) * 2007-10-01 2012-06-15 Dbv Tech Dispositif adhesif pour application cutanee
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
FR2924350B1 (fr) 2007-12-03 2010-08-13 Dbv Tech Procede et compositions pour la vaccination par voie cutanee
US20130060209A1 (en) * 2011-05-12 2013-03-07 Parker Campbell Tyler Athletic Tape
EP2979714A1 (de) * 2014-08-02 2016-02-03 LTS LOHMANN Therapie-Systeme AG Nadellose Injektionsvorrichtung aufweisend eine Membran

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233169B1 (enExample) * 1971-04-14 1977-08-26
US4831023A (en) * 1986-06-27 1989-05-16 Thames Pharmacal Co., Inc. Water washable vehicles for topical use
JPH06509254A (ja) * 1991-07-24 1994-10-20 アルザ・コーポレーション 経皮投与デバイス
JPH08509604A (ja) * 1993-04-08 1996-10-15 オックスフォード・バイオサイエンセス・リミテッド 粒子投入
JPH09507230A (ja) * 1993-12-30 1997-07-22 ビー． ロイズ，ロバート 経皮薬剤導入製剤
WO1997048485A1 (en) * 1996-06-17 1997-12-24 Powderject Research Limited Method for providing dense particle compositions for use in transdermal particle delivery
WO1998020734A1 (en) * 1996-11-14 1998-05-22 The Government Of The United States Of America, As Represented By The Secretary Of The Army Adjuvant for transcutaneous immunization
WO1998029134A2 (en) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
WO1998053847A1 (en) * 1997-05-29 1998-12-03 Ben Gurion University Of The Negev Research And Development Authority Transdermal delivery system

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233169B1 (enExample) * 1971-04-14 1977-08-26
US4831023A (en) * 1986-06-27 1989-05-16 Thames Pharmacal Co., Inc. Water washable vehicles for topical use
JPH06509254A (ja) * 1991-07-24 1994-10-20 アルザ・コーポレーション 経皮投与デバイス
JPH08509604A (ja) * 1993-04-08 1996-10-15 オックスフォード・バイオサイエンセス・リミテッド 粒子投入
JPH09507230A (ja) * 1993-12-30 1997-07-22 ビー． ロイズ，ロバート 経皮薬剤導入製剤
WO1997048485A1 (en) * 1996-06-17 1997-12-24 Powderject Research Limited Method for providing dense particle compositions for use in transdermal particle delivery
WO1998020734A1 (en) * 1996-11-14 1998-05-22 The Government Of The United States Of America, As Represented By The Secretary Of The Army Adjuvant for transcutaneous immunization
WO1998029134A2 (en) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
WO1998053847A1 (en) * 1997-05-29 1998-12-03 Ben Gurion University Of The Negev Research And Development Authority Transdermal delivery system

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006335754A (ja) * 2005-06-01 2006-12-14 Technofarm Axesz Kk 経皮投与剤担持薄膜とその製造法
JP2013539688A (ja) * 2010-10-07 2013-10-28 マサチューセッツ インスティテュート オブ テクノロジー ローレンツ力直動型の無針式ジェット注射システムを用いた固形物および／または流体の供給
JP2022553563A (ja) * 2019-11-01 2022-12-23 ダーレ エムビー インコーポレイテッド 二段階マイクロチップ薬物送達デバイスおよび方法
JP7834639B2 (ja) 2019-11-01 2026-03-24 ダーレ エムビー インコーポレイテッド 二段階マイクロチップ薬物送達デバイスおよび方法

Also Published As

Publication number Publication date
AU3065000A (en) 2000-08-07
EP1148902A1 (en) 2001-10-31
WO2000043058A1 (en) 2000-07-27
AU765429B2 (en) 2003-09-18
IL144380A (en) 2007-07-24
CA2358584A1 (en) 2000-07-27
IL144380A0 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
CN109528695B (zh) 一种治疗类风湿性关节炎的微针透皮给药贴片及其制备方法
ES2478623T3 (es) Perforador de solución sólido que contiene partículas de medicamentos y/o partículas adsorbentes de medicamentos
JP4829497B2 (ja) 薬物送達のための急速に溶解する微小穿孔器および他の適用
ES2333849T3 (es) Disposicion de microsalientes que presenta un revestimiento que contiene un agente beneficioso.
RU2282468C2 (ru) Устройство для трансдермальной доставки лекарственных средств, имеющее микровыступы с покрытием
Tiwary et al. Innovations in transdermal drug delivery: formulations and techniques
EP3040100B1 (en) Painless and patchless shooting microstructure
US7182747B2 (en) Solid solution perforator for drug delivery and other applications
US20140005606A1 (en) Embeddable micro-needle patch for transdermal drug delivery and method of manufacturing the same
KR20060127394A (ko) 경피 백신 전달 시스템 및 방법
KR20100098406A (ko) 체표 적용 제제 및 체표 적용 제제 보유 시트
KR20070011252A (ko) 초음파 보조 경피 백신전달방법 및 시스템
KR20070011240A (ko) 경피 송달 시스템 및 방법
TW200539907A (en) Delivery of polymer conjugates of therapeutic peptides and proteins via coated microprojections
WO2019029154A1 (zh) 一种经皮吸收组合物及其在制备经皮吸收制剂中的用途
KR20170000745A (ko) 광감응물질 전달용 용해성 미세바늘 패치
KR20170040767A (ko) 용해성 마이크로니들 마스크 키트
AU765429B2 (en) Method of enhancing needleless transdermal powdered drug delivery
JP7748878B2 (ja) 形成された経路を介した透過物送達パッチ
EP1956894B1 (en) Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
KR102313520B1 (ko) 흡수 속도를 개선한 마이크로니들 시스템
JP2002535293A5 (enExample)
Jain Transdermal drug delivery
US20070196490A1 (en) Method of enhancing needleless transdermal powered drug delivery
WO2007119467A1 (ja) 経皮吸収促進剤及びそれを用いた経皮吸収製剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100830

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110204